Evidence map›Paper›PMID 32122978›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2020

Dolutegravir for pregnant women living with HIV.

Jonathan Zipursky, Mona Loutfy

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Observational
  4. Article
  5. Article
  6. A practical clinical guide to counselling on and managing contraception, pre-conception planning, and menopause for women living with HIV.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jonathan ZipurskyDivision of Clinical Pharmacology and Toxicology (Zipursky), Department of Medicine, and Institute of Health Policy, Management, and Evaluation (Zipursky), University of Toronto; Women's College Research Institute (Loutfy); Division of Infectious Diseases (Loutfy), Department of Medicine, University of Toronto, Toronto, Ont. jonathan.zipursky@mail.utoronto.ca.
Mona LoutfyDivision of Clinical Pharmacology and Toxicology (Zipursky), Department of Medicine, and Institute of Health Policy, Management, and Evaluation (Zipursky), University of Toronto; Women's College Research Institute (Loutfy); Division of Infectious Diseases (Loutfy), Department of Medicine, University of Toronto, Toronto, Ont.
University of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CanadaDolutegravirFemaleHeterocyclic Compounds, 3-RingHIV InfectionsHIV Integrase InhibitorsHumansNeural Tube DefectsOxazinesPiperazinesPractice Guidelines as TopicPregnancyPregnancy Complications, InfectiousPyridonesDolutegravirHeterocyclic Compounds, 3-RingHIV Integrase InhibitorsOxazinesPiperazinesPyridones

Identifiers

PMID32122978
PMCPMC7055948
OpenAlexW3010006418

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.